BPA
CRL icon

Beacon Pointe Advisors’s Charles River Laboratories CRL Stock Holding History

Beacon Pointe Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-993
Closed -$200K – 1069
2022
Q3 		$200K Sell
993
-2,423
-71% -$523K ﹤0.01% 929
2022
Q2 		$727K Sell
3,416
-1,980
-37% -$484K 0.02% 550
2022
Q1 		$1.53M Buy
5,396
+4,462
+478% +$1.38M 0.02% 508
2021
Q4 		$352K Sell
934
-8,846
-90% -$3.44M 0.01% 673
2021
Q3 		$4.04M Buy
+9,780
New +$4.06M 0.1% 191

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Beacon Pointe Advisors's CRL Position: Q4 2022 in Review

Beacon Pointe Advisors sold out of Charles River Laboratories (CRL) in Q4 2022, closing a stake of 993 shares — an estimated $200K sold.

Beacon Pointe Advisors first reported a position in CRL in Q3 2021 and held it in 5 quarters. The position peaked at $4.04M in Q3 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q4 2022.

  • Beacon Pointe Advisors reported no remaining Charles River Laboratories position as of Q4 2022 after selling out during the quarter.
  • Beacon Pointe Advisors sold 993 Charles River Laboratories shares in Q4 2022, an estimated $200K.
  • Beacon Pointe Advisors first reported a position in Charles River Laboratories in Q3 2021 and held it in 5 quarters.
  • Beacon Pointe Advisors's Charles River Laboratories position peaked at $4.04M in Q3 2021.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2022.

Based on Beacon Pointe Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.